PHAXIAM Therapeutics S.A. (PHXM)

PHAXIAM Therapeutics Revenue

PHAXIAM Therapeutics had revenue of $6.56M in the twelve months ending June 30, 2023. In the year 2022, PHAXIAM Therapeutics had annual revenue of $32.98M with 594.24% growth.

• Revenue (ttm): $6.56M
• Revenue Growth: +594.24%
• P/S Ratio: 4.40
• Revenue / Employee: $133,931
• Employees: 49
• Market Cap: 28.90M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	32.98M	28.23M	594.24%
Dec 31, 2021	4.75M	215.85K	4.76%
Dec 31, 2020	4.53M	-1.40M	-23.62%
Dec 31, 2019	5.94M	824.46K	16.13%
Dec 31, 2018	5.11M	1.07M	26.62%
Dec 31, 2017	4.04M	-317.91K	-7.30%
Dec 31, 2016	4.35M	1.17M	36.89%
Dec 31, 2015	3.18M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.